| 2D Structure | |
| CID | 5983 |
| IUPAC Name | [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate |
| InChI | InChI=1S/C15H21N3O2/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2/h5-6,9,13H,7-8H2,1-4H3,(H,16,19)/t13-,15+/m1/s1 |
| InChI Key | PIJVFDBKTWXHHD-HIFRSBDPSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C15H21N3O2 |
| Molecular Weight | 275.35 |
| synonyms | ['physostigmine', 'Eserine', '57-47-6', 'Physostol', 'Esromiotin', '(-)-physostigmine', 'Ezerin', 'Calabarine', 'Fysostigmin', 'Erserine', 'cogmine', 'eserin', 'Eserinum', 'Eserolein, methylcarbamate (ester)', 'DTXSID3023471', 'MCV 4484', 'MCV-4484', 'NIH 10421', 'NSC-30782', '9U1VM840SP', 'Methyl-carbamic acid, ester with eseroline', 'Carbamic acid, methyl-, ester with eseroline', 'DTXCID603471', 'Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-', 'CHEBI:27953', '(3aS-cis)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-ol methylcarbamate (ester)', '(3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N-methylcarbamate', '[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate', '((3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo(2,3-b)indol-7-yl) N-methylcarbamate', '(3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo(2,3-b)indol-5-yl N-methylcarbamate', 'RefChem:56714', '200-332-8', 'Antilirium', '(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate', 'NSC30782', 'CHEMBL94', 'NCGC00093889-03', 'Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)', 'Fysostigmin [Czech]', 'CHEMBL537674', 'CAS-57-47-6', 'CCRIS 3422', 'HSDB 3161', 'EINECS 200-332-8', 'Eserolein, methylcarbamate', 'NSC 30782', 'Physostigmine [USP:BAN]', 'RCRA waste no. P204', 'physostigmin', 'UNII-9U1VM840SP', 'CS 58525', '(-) physostigmine', 'Eserine (TN)', 'Physostigmine (USP)', 'Spectrum_000916', 'Spectrum_001789', 'ESERINUM [HPUS]', 'SpecPlus_000381', 'Prestwick0_000566', 'Prestwick1_000566', 'Prestwick2_000566', 'Prestwick3_000566', 'Spectrum2_000330', 'Spectrum2_000757', 'Spectrum2_001283', 'Spectrum3_000545', 'Spectrum3_000901', 'Spectrum4_000997', 'Spectrum4_001631', 'Spectrum4_001913', 'Spectrum5_000441', 'Spectrum5_000626', 'Spectrum5_001672', 'PHYSOSTIGMINE [MI]', 'physostigmine.salicylic acid', '1,2,3,3abeta,8abeta-Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)-indol-5-yl methylcarbamate', 'PHYSOSTIGMINE [HSDB]', 'Lopac0_000483', 'SCHEMBL24044', 'BSPBio_000352', 'BSPBio_002189', 'KBioGR_001433', 'KBioGR_002061', 'KBioGR_002533', 'KBioSS_001396', 'KBioSS_002279', 'PHYSOSTIGMINE [VANDF]', 'MLS001304022', 'orb104785', 'DivK1c_006477', 'PHYSOSTIGMINE [MART.]', 'SPECTRUM1500753', 'SPBio_000339', 'SPBio_000774', 'SPBio_001285', 'SPBio_002571', 'PHYSOSTIGMINE [WHO-DD]', 'BPBio1_000388', 'cid_657348', 'GTPL6598', 'MEGxp0_001872', 'SCHEMBL29482277', 'ACon1_000097', 'BDBM11023', 'KBio1_001421', 'KBio2_001396', 'KBio2_002278', 'KBio2_003964', 'KBio2_004846', 'KBio2_006532', 'KBio2_007414', 'KBio3_001689', 'KBio3_001842', 'Eserolein,methylcarbamate (ester)', 'HMS1921G06', 'HMS2089M11', 'HMS2236L08', 'HMS3261B07', 'Carbamic acid, ester with eseroline', 'HY-N6608', 'MSK40315', 'PHYSOSTIGMINE [USP IMPURITY]', 'Tox21_111228', 'Tox21_301591', 'Tox21_500483', 'BDBM50004000', 'BDBM50222010', 'CCG-38605', 'EBC-26402', 'AKOS016843649', 'Tox21_111228_1', 'DB00981', 'FE59473', 'LP00483', 'SDCCGMLS-0066585.P001', 'SDCCGSBI-0050467.P005', 'NCGC00093889-01', 'NCGC00093889-02', 'NCGC00093889-04', 'NCGC00093889-05', 'NCGC00093889-06', 'NCGC00093889-07', 'NCGC00093889-08', 'NCGC00093889-09', 'NCGC00093889-10', 'NCGC00093889-12', 'NCGC00093889-13', 'NCGC00093889-20', 'NCGC00255345-01', 'NCGC00261168-01', 'AC-15983', 'AC-37456', 'DA-56831', 'Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS,8aR)-', 'SMR000718753', 'SBI-0050467.P004', 'CS-0034353', 'EU-0100483', 'NS00004015', 'P0406', 'Physostigmine 100 microg/mL in Acetonitrile', 'C06535', 'D00196', 'E 8375', 'G60920', 'EN300-23839407', 'Q410595', 'SR-01000075341-1', 'WLN: T B556 EN GNTT&J B1 E1 G1 KOVM1', 'BRD-K25650355-001-02-5', 'BRD-K25650355-059-02-3', 'BRD-K25650355-059-12-2', 'BRD-K25650355-059-18-9', 'BRD-K25650355-065-02-0', '(3aS,8aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl hydrogen methylcarbonimidate', '(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate hydrochloride', '(3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N-methylcarbamate; 2-hydroxybenzoic acid', '1,2,3,3A.BETA.,8A.BETA.-HEXAHYDRO-1,3A,8-TRIMETHYLPYRROLO(2,3-B)-INDOL-5-YL METHYLCARBAMATE', 'Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, 5-(N-methylcarbamate), (3aS,8aR)-', 'Pyrrolo[2, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-'] |
From Pubchem